Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu City, Fukuoka, Japan.
Department of Clinical Microbiology, Kyurin Medical Laboratory, Kitakyushu City, Fukuoka, Japan.
PLoS One. 2019 Jul 8;14(7):e0218589. doi: 10.1371/journal.pone.0218589. eCollection 2019.
Chromosomal AmpC β-lactamase induction by several types of β-lactams has been reported, but not enough data are available on DHA-1 β-lactamase, a plasmid-mediated AmpC β-lactamase. Therefore, we evaluated the DHA-1 β-lactamase induction by various antibiotics including piperacillin/tazobactam (PIP/TZB) in this study. Six strains (Enterobacter cloacae 2 strains, Citrobacter freundii 1 strain, Serratia marcescens 2 strain, and Morganella morganii 1 strain) possessing chromosomal inducible AmpC β-lactamase were used as controls. Four strains (Escherichia coli 2 strains, Klebsiella pneumoniae 1 strain, and C. koseri 1 strain) possessing DHA-1 β-lactamase were used. The β-lactamase activities were determined by a spectrophotometer using nitrocefin. β-lactamase induction by PIP, PIP/TZB was not observed in any strains and β-lactamase induction by third- and fourth-generation cephems was not observed in most strains. The induction ratios of the chromosomal AmpC β-lactamase in the reference group by PIP/TZB were <1.51, and those of the DHA-1 β-lactamase were <1.36, except for K. pneumoniae Rkp2004 (2.22). The β-lactamase induction by first- and second-generation cephems, flomoxef, and carbapenem differed in each strain. Cefmetazole (CMZ) strongly induced β-lactamase. This study demonstrated that the induction of DHA-1 β-lactamase was similar to that of chromosomal AmpC using various Enterobacteriaceae, although the induction of β-lactamase in both groups by PIP/TZB was low. We also reported that the induction of PIP/TZB, a β-lactamase inhibitor combination antibiotic, against various AmpC-producing Enterobacteriaceae, including DHA-1 producers, was low.
已报道多种β-内酰胺类抗生素可诱导染色体型AmpCβ-内酰胺酶,但有关DHA-1β-内酰胺酶(一种质粒介导的AmpCβ-内酰胺酶)的诱导数据还不够充分。因此,本研究评估了包括哌拉西林/他唑巴坦(PIP/TZB)在内的各种抗生素对DHA-1β-内酰胺酶的诱导作用。本研究使用了 6 株(阴沟肠杆菌 2 株、弗氏柠檬酸杆菌 1 株、粘质沙雷菌 2 株和摩氏摩根菌 1 株)具有染色体诱导型 AmpCβ-内酰胺酶的菌株作为对照,还使用了 4 株(大肠埃希菌 2 株、肺炎克雷伯菌 1 株和产酸克雷伯菌 1 株)具有 DHA-1β-内酰胺酶的菌株。采用分光光度计法用硝噻吩(nitrocefin)测定β-内酰胺酶活性。在任何菌株中均未观察到 PIP 和 PIP/TZB 对β-内酰胺酶的诱导作用,也未观察到第三代和第四代头孢菌素对大多数菌株β-内酰胺酶的诱导作用。参考组中 PIP/TZB 对染色体型 AmpCβ-内酰胺酶的诱导比值均<1.51,除肺炎克雷伯菌 Rkp2004(2.22)外,DHA-1β-内酰胺酶的诱导比值均<1.36。第一代和第二代头孢菌素、头孢呋辛和碳青霉烯类药物在各菌株中的诱导作用不同。头孢美唑(CMZ)可强烈诱导β-内酰胺酶。本研究表明,在各种肠杆菌科细菌中,DHA-1β-内酰胺酶的诱导作用与染色体型 AmpCβ-内酰胺酶相似,尽管 PIP/TZB 对两组β-内酰胺酶的诱导作用均较低。我们还报告了 PIP/TZB(一种β-内酰胺酶抑制剂复合抗生素)对包括 DHA-1 产生菌在内的各种产 AmpC 肠杆菌科细菌的诱导作用较低。